Young-Onset Dementia: 3.9 Million of Working Age, and Years to a Diagnosis

Around 3.9 million people aged 30 to 64 are living with young-onset dementia worldwide, and about 370,000 more are diagnosed each year. In the countries that have measured it, they wait years for a diagnosis, often longer than older people do, and many lose their work and income on the way.

Young-onset dementia is dementia whose symptoms begin before the age of 65. It arrives in the middle of working life: while people are holding down jobs, running households, raising children or caring for their own parents. Changes in memory, mood or behaviour are often put down to stress, depression or the menopause before anyone thinks of dementia, and services built around people in their eighties can feel a poor fit. This study brings together the best global evidence on how common young-onset dementia is, what causes it, how long diagnosis takes and what it means for work, family and survival.

Young-onset dementia affects millions of people of working age worldwide

The most complete estimate comes from a 2021 systematic review and meta-analysis in JAMA Neurology, which reviewed 95 population-based studies published between 1990 and 2020 and pooled 74 of them in its meta-analysis. Standardised to the World Standard Population, prevalence rose steeply with age, from 1.1 per 100,000 people aged 30 to 34 to 77.4 per 100,000 at ages 60 to 64. Across the whole 30 to 64 age range the global age-standardised prevalence was 119.0 per 100,000, which the authors translated into 3.9 million people living with young-onset dementia^[1]. A companion meta-analysis of 61 incidence studies, published in 2023, put the global age-standardised incidence at 11 per 100,000 people aged 30 to 64, or about 370,000 new cases each year^[4].

The World Health Organization’s dementia fact sheet says young-onset dementia accounts for up to 9% of all cases^[5]. A different modelling approach, the Global Burden of Disease Study 2021, estimated 7.75 million people with early-onset dementia worldwide in 2021 (95% uncertainty interval 5.82 to 10.08 million) and 73,386 deaths. It found the age-standardised rate essentially flat since 1990: the number of people affected is rising because populations are growing and aging, not because the risk at any given age has changed much^[6]. The two global figures are not in conflict so much as built differently, and the gap between them is itself a measure of how uncertain the evidence remains.

That uncertainty is greatest where data are thinnest. The 2021 review found most studies came from Europe, with few from low-income countries or from people in their thirties and forties^[1]. Where careful local case-finding has been done, figures vary. In central Norway, a study that searched hospital databases, records and community contacts found 76.3 people per 100,000 aged 30 to 65, rising to 163.1 per 100,000 at ages 45 to 64, higher than earlier estimates from England and Japan^[7]. In Girona, Spain, a regional dementia register recorded an incidence of 13.4 per 100,000 person-years at ages 30 to 64, and 6.9% of all new dementia diagnoses there had onset before 65^[8].

Alzheimer’s disease is the most common cause, but the mix is wider than in later life

Alzheimer’s disease is the single largest cause of young-onset dementia in the registers with good data, but it accounts for a smaller share than in older age groups, and the rest is unusually varied. In Girona’s register, Alzheimer’s disease made up 42.4% of early-onset cases, followed by secondary dementias (18.1%), vascular dementia (13.8%) and frontotemporal dementia (9.7%)^[8]. In Japan, where 440 specialist Medical Centers for Dementia report every new diagnosis, 52.1% of the 1,733 early-onset cases diagnosed in 2018–19 were due to Alzheimer’s disease, 8.9% were frontotemporal, 8.8% vascular, 7.1% substance- or medication-induced and 6.5% dementia with Lewy bodies^[9].

Clinicians describe the range of causes in younger people as heterogeneous: as well as Alzheimer’s, frontotemporal and vascular dementias, it includes genetic and familial dementias, metabolic disorders, and secondary dementias resulting from alcohol use disorder, traumatic brain injury and infections^[10]. England’s national dementia guideline asks clinicians to be aware that young-onset Alzheimer’s disease, and young-onset vascular dementia, have a genetic cause in some people^[11]. Our study of dementia subtypes and diagnosis covers the types in more detail.

Risk factors that are mostly modifiable

Young-onset dementia is often assumed to be mainly genetic. The largest prospective study so far suggests a broader picture. Among 356,052 UK Biobank participants under 65, followed for an average of about eight years (up to about 15), 485 developed young-onset dementia, an incidence of 16.8 per 100,000 person-years. Fifteen factors were associated with a higher risk: lower formal education, lower socioeconomic status, carrying two copies of the apolipoprotein E ε4 allele, no alcohol use, alcohol use disorder, social isolation, vitamin D deficiency, high C-reactive protein, lower handgrip strength, hearing impairment, orthostatic hypotension, stroke, diabetes, heart disease and depression. The authors note that most of these are modifiable^[12]. These are associations in an observational cohort, not proof that any one factor causes dementia in an individual; our study of dementia risk factors looks at prevention evidence across all ages.

Diagnosis takes years, and often longer than for older people

Studies in several countries agree that the road to a diagnosis of young-onset dementia is long. In the Netherlands, data on 235 people with young-onset and 167 with late-onset dementia from two cohort studies showed that the time from first symptoms to diagnosis averaged 4.4 years for young-onset dementia, against 2.8 years for late-onset dementia, a gap of 1.6 years. Younger age and frontotemporal dementia were linked to longer delays; vascular dementia to shorter ones^[2].

Australia’s INSPIRED study mapped each step for 88 people whose symptoms began before 65 (on average at 55.4). The median time from first symptoms to a first consultation was 2.3 years, to a dementia diagnosis 3.2 years, to the family knowing the diagnosis 3.5 years, and to a final diagnosis of the type of dementia 4.7 years. Almost half (48.9%) were first given a diagnosis other than dementia, most often depression (30.7%) or mild cognitive impairment (17.0%), and those who presented with depression or mild cognitive impairment waited longer for a dementia diagnosis^[13].

The signs are often there earlier than anyone recognises. A Dutch primary-care register study comparing 89 people later diagnosed with young-onset dementia with 162 matched controls found cognitive symptoms recorded more often in GP notes five years before diagnosis, affective symptoms four years before, social symptoms three years before and behavioural symptoms two years before^[14]. A 2023 clinical review describes a recurring question in practice: “Is this young-onset dementia or is this psychiatric?”^[10] None of this is a failing of the people concerned. It reflects services, and expectations, that do not yet look for dementia in people of working age.

Work and income are lost long before, and soon after, a diagnosis

Because young-onset dementia arrives during working life, its economic effects fall on households as well as health systems. A Finnish register study followed the incomes of 793 people diagnosed with early-onset dementia between 2010 and 2021 alongside 7,926 matched controls, using national tax records. Income losses relative to controls grew steadily over the 15 years before diagnosis, reaching a cumulative €74,577 per person (95% CI €46,423 to €102,732). For people with Alzheimer’s disease, a measurable loss emerged six years before diagnosis^[15]. In other words, many people are already losing work and earnings during the years they are waiting to be diagnosed.

A diagnosis does not end the risk. In a Japanese matched cohort using a health claims database, 143 employees diagnosed with early-onset dementia were followed for about 600 days alongside five matched controls each. Those with dementia left their jobs at 2.26 times the rate of the controls (a hazard ratio), and the authors called for employment support to be offered just after diagnosis^[3]. In a small UK online survey of 55 people aged 45 to 64 with a diagnosis, the main financial impact reported was premature loss of income; some respondents also described unclear needs, carer and financial assessment processes, with some families having to seek legal advice or go through lengthy appeals^[16].

Families reshape their own working lives

Partners and children often provide the care, while still of working age themselves. A 2024 scoping review found 16 studies on how caring for a family member with young-onset dementia affects carers’ employment, volunteering and education. Its central theme was decision-making: family members repeatedly choosing between their own jobs, studies and goals and the care needed. The authors found the evidence scarce and mostly descriptive, with little on long-term effects^[17]. A 2023 Australian clinical review argues that care should be age-appropriate and multidisciplinary, and should consider the whole family, including children^[10]. The wider evidence on family carers is in our study of unpaid dementia carers.

Survival is shorter, and support after diagnosis is uneven

Young-onset dementia shortens life considerably, though many people live with it for a decade or more. In two regions of Finland, where every new case diagnosed between 2010 and 2021 was re-checked against clinic records, median survival after diagnosis was 8.7 years: 9.9 years for Alzheimer’s disease, 7.0 years for alpha-synucleinopathies and 6.9 years for frontotemporal dementia. Mortality was 6.56 times that of matched controls without neurodegenerative disease (hazard ratio, 95% CI 5.56 to 7.74)^[18]. In the Dutch NeedYD cohort of 198 people, mean survival was 120 months after diagnosis and 209 months after first symptoms, and remaining life expectancy after diagnosis was 51% lower for men and 59% lower for women than in the general population of the same age^[19].

What happens after diagnosis matters as much as how quickly it comes. In a Dutch primary-care register study of 75 people with young-onset dementia, 72% were assigned a case manager, 42.7% received day care and 44% moved into long-term care. Admission to long-term care was more common among those without a case manager (64%) than those with one (36%), and reasons care was not started included the GP not referring^[20]. That comparison is small and observational, so it cannot show that case management prevents admission, but it points to where support can be strengthened. Our study of post-diagnostic support looks at the gaps across all ages.

What the evidence asks of us

The figures point to a group of people whose needs are well documented but whom services still struggle to see. They suggest several things that health systems, employers, funders and policymakers can do.

• Count people with young-onset dementia. Global prevalence rests largely on European studies, with little from low-income countries or from people under 45^[1]. National dementia strategies and registers can report diagnoses by age at onset so that services can be planned for the 3.9 million people the global estimate implies.
• Shorten the road to diagnosis. Delays of three to four and a half years, and first diagnoses of depression or mild cognitive impairment in many cases^[2][13], argue for awareness among GPs, psychiatrists and occupational health services, and for clear referral routes to specialists who can investigate the less common causes, including genetic ones^[11].
• Protect work and income. Earnings fall years before diagnosis and job loss is more likely soon after it^[15][3]. Employment support at diagnosis, reasonable adjustments and clear, joined-up benefit and social care assessments would address the problems people with young-onset dementia themselves report^[16]. England’s guideline already asks that staff training cover the specific needs of younger people living with dementia and people who are working or looking for work^[11].
• Make support age-appropriate and family-wide. Care built for people in their eighties often does not fit people in their fifties. Case management, day services and support for partners and children, including help to stay in work or education, should be designed with them^[20][17][10].
• Fund research on prevention and on what helps. Most risk factors linked to young-onset dementia in the largest cohort were modifiable^[12], while evidence on carers’ work and long-term outcomes remains scarce^[17].

Language: this piece uses person-first language ("people living with dementia", "people with dementia"), as most dementia organisations and people with lived experience prefer, and uses clinical terms such as "Alzheimer's disease" or "mild cognitive impairment" only where a study, dataset or diagnosis refers to that specific condition.

Why we're publishing this

People living with young-onset dementia, and the partners, children and friends who support them, often say they have to explain their own condition to the professionals around them. We compiled this evidence so that young-onset dementia organisations, dementia charities and carers’ groups in any country have the best global figures in one place, cleanly sourced, to put in front of commissioners, employers, ministers and journalists. The case is theirs; the data supports it. The wider library is at Dementia & Health research.

How to read this data

Young-onset dementia means symptom onset before age 65; some studies use age at diagnosis instead, and the lower age limit varies (30, 18 or none), so rates are not directly comparable between studies. The global prevalence and incidence figures are pooled, age-standardised meta-analysis estimates drawn mostly from European studies; the Global Burden of Disease figure is a separate model with wide uncertainty. Register studies (Girona, Japan, Finland) count people diagnosed in services, so they miss people never referred and will understate true incidence. Time-to-diagnosis studies rely partly on carers recalling when symptoms began. Hazard ratios compare rates over time between matched groups and are not simple risks. Risk-factor findings are associations in an observational cohort of UK volunteers, who tend to be healthier than the general population. Several studies are small (55 to 198 people) and from single countries; we say which country, period and design each figure comes from, and where we could see only an abstract we used only what the abstract reports.

Use this data

Free to cite with attribution to Understanding Aging. Charities, carers' groups, campaigners and journalists are welcome to reuse these figures and charts. For the underlying figures as a spreadsheet, get in touch.

Important: This article summarises published research and statistics for general information. It is not medical, care or financial advice and cannot be used to diagnose, treat or predict anything about an individual. If you have concerns about your own or someone else's memory or health, please speak to a GP or another qualified health professional.

Sources

1. Hendriks S, Peetoom K, Bakker C, et al. Global prevalence of young-onset dementia: a systematic review and meta-analysis. JAMA Neurology, 2021. europepmc.org/article/MED/34279544
2. van Vliet D, de Vugt ME, Bakker C, et al. Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychological Medicine, 2013. europepmc.org/article/MED/22640548
3. Sakata N, Okumura Y. Job loss after diagnosis of early-onset dementia: a matched cohort study. Journal of Alzheimer’s Disease, 2017. europepmc.org/article/MED/29036820
4. Hendriks S, Peetoom K, Bakker C, et al. Global incidence of young-onset dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia, 2023. europepmc.org/article/MED/35715891
5. World Health Organization. Dementia (fact sheet). WHO, 2026. who.int/news-room/fact-sheets/detail/dementia
6. Feng S, Wang T, Su Y, et al. Global burden, risk factors, and projections of early-onset dementia: insights from the Global Burden of Disease Study 2021. Ageing Research Reviews, 2025. europepmc.org/article/MED/39701185
7. Kvello-Alme M, Bråthen G, White LR, Sando SB. The prevalence and subtypes of young onset dementia in central Norway: a population-based study. Journal of Alzheimer’s Disease, 2019. europepmc.org/article/MED/31006688
8. Garre-Olmo J, Genís Batlle D, del Mar Fernández M, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology, 2010. europepmc.org/article/MED/20810999
9. Edahiro A, Miyamae F, Taga T, et al. Incidence and distribution of subtypes of early-onset dementia in Japan: a nationwide analysis based on annual performance reports of the Medical Centers for Dementia. Geriatrics & Gerontology International, 2020. europepmc.org/article/MED/32989857
10. Loi SM, Cations M, Velakoulis D. Young-onset dementia diagnosis, management and care: a narrative review. Medical Journal of Australia, 2023. europepmc.org/article/MED/36807325
11. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers (NG97), recommendations. NICE, 2018. nice.org.uk/guidance/ng97/chapter/Recommendations
12. Hendriks S, Ranson JM, Peetoom K, et al. Risk factors for young-onset dementia in the UK Biobank. JAMA Neurology, 2024. europepmc.org/article/MED/38147328
13. Draper B, Cations M, White F, et al. Time to diagnosis in young-onset dementia and its determinants: the INSPIRED study. International Journal of Geriatric Psychiatry, 2016. europepmc.org/article/MED/26807846
14. Hendriks S, Peetoom K, Tange H, et al. Pre-diagnostic symptoms of young-onset dementia in the general practice up to five years before diagnosis. Journal of Alzheimer’s Disease, 2022. europepmc.org/article/MED/35570494
15. Kivisild A, Aaltonen M, Aho K, et al. Long-term income and productivity losses in individuals with early-onset dementia: evidence from 15 years preceding the diagnosis. Neurology, 2026. europepmc.org/article/MED/42418748
16. Mayrhofer AM, Greenwood N, Smeeton N, et al. Understanding the financial impact of a diagnosis of young onset dementia on individuals and families in the United Kingdom: results of an online survey. Health & Social Care in the Community, 2021. europepmc.org/article/MED/33745216
17. Kokorelias KM, Nadesar N, Bak K, et al. The impact on employment and education of caregiving for a family member with young onset dementia: a scoping review. Dementia, 2024. europepmc.org/article/MED/38623057
18. Katisko K, Aaltonen M, Aho K, et al. Survival and mortality rates in early onset dementia. Journal of Neurology, Neurosurgery and Psychiatry, 2026. europepmc.org/article/MED/41188051
19. Gerritsen AAJ, Bakker C, Verhey FRJ, et al. Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up: the NeedYD-study. International Psychogeriatrics, 2019. europepmc.org/article/MED/30915930
20. Hendriks S, Peetoom K, Tange H, et al. Diagnosis and care use for people with young-onset dementia in primary care in the Netherlands. Journal of Alzheimer’s Disease, 2023. europepmc.org/article/MED/36502322